News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Earnings
Amgen (AMGN) Announces Webcast Of 2014 Fourth Quarter And Full Year Financial Results 1/23/2015
Catalent, Inc. Announces Second Quarter Fiscal Year 2015 Earnings Conference Webcast 1/23/2015
HEALTHSOUTH Announces Date Of 2014 Fourth Quarter Earnings Conference Call 1/22/2015
Perrigo Company plc To Release Second Quarter Fiscal Year 2015 Results On February 5, 2015 1/22/2015
ImmunoGen, Inc. (IMGN) Announces Conference Call To Discuss Its Second Quarter Fiscal Year 2015 Financial Results 1/22/2015
Affymetrix (Santa Clara, California) (AFFX) To Report Fourth Quarter And Fiscal Year 2014 Operating Results On Wednesday February 4, 2015 1/22/2015
Meridian Bioscience, Inc. (VIVO) Reports First Quarter 2015 Operating Results, Declares Regular Cash Dividend, And Reaffirms Fiscal 2015 Guidance 1/22/2015
Dr. Reddy's Laboratories Ltd. (RDY)'s To Release Q3 FY15 Results On January 29, 2015 1/22/2015
Getinge Announces Date of 2014 Q4 Report and Conference Call 1/21/2015
Seattle Genetics, Inc. (SGEN) To Host Conference Call And Webcast Discussion Of Fourth Quarter And Year 2014 Financial Results On February 10, 2015 1/21/2015
Alexion Pharmaceuticals Inc. (ALXN) To Report Fourth Quarter And Full Year 2014 Results On Thursday, January 29, 2015 1/21/2015
Johnson & Johnson (JNJ) Reports 2014 Fourth-Quarter And Full-Year Results 1/20/2015
Medivir AB (MVRBF): OLYSIO® Sales During The Fourth Quarter 2014 1/20/2015
McKesson Corporation Fiscal 2015 Third Quarter Conference Call Scheduled For February 5, 2015 1/20/2015
Eagle Pharmaceuticals (EGRX) Announces Change In Fiscal Year End 1/20/2015
Quintiles’ Fourth Quarter 2014 Earnings Call Scheduled For Thursday, February 12th 1/19/2015
AbbVie (ABBV) To Host Fourth-Quarter And Full-Year 2014 Earnings Conference Call 1/16/2015
Teva Pharmaceutical Industries Limited (TEVA) To Report Fourth Quarter 2014 Financial Results On February 5, 2015 1/16/2015
PerkinElmer, Inc. (PKI) To Hold Earnings Call On Thursday, January 29, 2015 1/16/2015
Oncologix Tech, Inc.  (OTCBB: OCLG) Announces 1st Quarter Fiscal 2015 Financial Results Showing, New Business, Solid Revenue Growth And Continued Financial Improvements 1/16/2015
Biomerica (BMRA) Announces Second Quarter Financial Results 1/15/2015
Simulations Plus (SLP) Announces Quarterly Cash Dividend Of $0.05 Per Share 1/15/2015
Acasti Pharma Announces Third Quarter Results 1/14/2015
Neptune Technologies & Bioressources Inc. Announces Third Quarter Results 1/14/2015
Dendreon Corporation (DNDN) Announces Strong Commercial Start To 2015 1/14/2015
Fluidigm Corporation Announces Preliminary Fourth Quarter 2014 Revenue And Issues 2015 Revenue Guidance 1/14/2015
J.P. Morgan: Gilead Sciences, Inc. (GILD) President Says 48% of Revenue Comes From Hep C Drugs 1/13/2015
Pharmacyclics, Inc. (PCYC) Announces Preliminary 2014 U.S. Net Product Revenue Results And 2015 U.S. Net Product Revenue Outlook 1/13/2015
Illumina (ILMN) To Announce Fourth Quarter And Fiscal Year 2014 Financial Results On Tuesday, January 27, 2015 1/13/2015
Pacific Biosciences (PACB) Fourth Quarter And Year End 2014 Financial Results Call 1/12/2015
Emergent BioSolutions (EBS) Announces Preliminary 2014 Financial Results And Provides 2015 Financial Outlook 1/12/2015
AMAG Pharmaceuticals, Inc. (AMAG) Provides Business Update And 2015 Financial Guidance 1/12/2015
Adamas Pharmaceuticals (ADMS) Provides Review Of 2014 And Previews Upcoming Business Drivers 1/12/2015
Aegerion Pharmaceuticals, Inc. (AEGR) Reports Preliminary 2014 Net Product Sales, Its Outlook For 2015 And Other Business Updates 1/12/2015
Novadaq Corp. Announces Fourth Quarter 2014 Preliminary Unaudited Revenues And Issues 2015 Revenue Guidance 1/12/2015
BioLife Solutions, Inc. (BLFS.OB) Reports Preliminary Revenue for 2014 1/12/2015
IRIDEX Corporation (IRIX) Announces Preliminary Unaudited Revenues For 2014 Fourth Quarter And Full Year; 2015 Revenue Outlook 1/12/2015
Actavis (ACT) Announces Exceptional Preliminary Fourth Quarter 2014 Performance 1/12/2015
AmerisourceBergen Corporation (ABC) Announces Date And Time For First Quarter Fiscal 2015 Earnings Release 1/12/2015
Affymetrix (Santa Clara, California) (AFFX) Announces Preliminary Fourth Quarter 2014 Revenue Of Approximately $93 Million And The Appointment Of Merilee Raines To The Board Of Directors 1/12/2015
Simulations Plus (SLP) Reports First Quarter FY2015 Financial Results 1/12/2015
Celgene (CELG) Announces 2015 And Long-Term Financial Outlook And Preliminary 2014 Results 1/12/2015
Regeneron (REGN) To Report Fourth Quarter And Full Year 2014 Financial And Operating Results And Host Conference Call And Webcast On February 10, 2015 1/9/2015
Simulations Plus (SLP) Sets Date For 1st Quarter 2015 Earnings Release And Conference Call 1/9/2015
Isis Pharmaceuticals, Inc. (ISIS) Significantly Improves Upon 2014 Financial Guidance 1/8/2015
Abbott Laboratories (ABT) Hosts Conference Call For Fourth-Quarter And Full-Year 2014 Earnings 1/8/2015
Derma Sciences, Inc. (DSCI) Introduces 2015 Financial Guidance And Provides 2014 Preliminary Net Sales 1/8/2015
Pacira Pharmaceuticals, Inc. (PCRX) Reports Estimated Fourth Quarter Total Revenue Of $61.8 Million And Estimated Full-Year Total Revenue Of $197.7 Million 1/8/2015
SciClone Pharmaceuticals, Inc. (SCLN) Provides 2014 Financial Update And 2015 Revenue Guidance 1/8/2015
Reminder: Centene Corporation's 2014 Fourth Quarter And Year-End Financial Results Conference Call 1/7/2015
Mesa Labs (MLAB) Declares Quarterly Dividend 1/7/2015
Neptune Technologies & Bioressources Inc. To Hold Conference Call To Discuss Third Quarter Results 1/6/2015
Mallinckrodt Pharmaceuticals (MNK) To Report First Quarter Fiscal 2015 Results On February 3, 2015 1/6/2015
Cardinal Health To Release Second-Quarter Results For Fiscal Year 2015 On Jan. 29 1/6/2015
Johnson & Johnson (JNJ) Announces Quarterly Dividend For First Quarter 2015 1/5/2015
Merck & Co. (MRK) To Hold Fourth-Quarter And Full-Year 2014 Sales And Earnings Conference Call On February 4 1/5/2015
Anavex Life Sciences Corp. (AVXL.OB) Announces Fiscal 2014 Fourth Quarter And Year-End Financial Results 12/30/2014
Tianyin Pharmaceutical Co, Inc. Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12/29/2014
CEL-SCI (CVM) Reports Fiscal 2014 Financial Results And Clinical & Corporate Developments 12/29/2014
Microbix Biosystems Inc. (MBXBF) Reports Strong Growth In Revenue And Operating Profit In 2014 12/29/2014
Biogen Idec (BIIB) To Report Fourth Quarter And Year End 2014 Financial Results On January 28, 2015 12/24/2014
CEL-SCI (CVM) Reports Fiscal 2014 Financial Results And Clinical & Corporate Developments 12/24/2014
Ohr Pharmaceutical (OHRP) Reports Fiscal Year 2014 Financial and Business Results 12/23/2014
Apricus Biosciences (APRI) Announces Year-End 2014 Update And 2015 Plans To Advance Its Clinical Pipeline And Further Commercialize Its Erectile Dysfunction Drug Vitaros® 12/22/2014
BASi (BASI) Reports Fourth Quarter And Full Year 2014 Results 12/22/2014
Ohr Pharmaceutical (OHRP) To Announce Fiscal 2014 Financial Results And Host Conference Call On Monday, December 22 12/19/2014
CAPNIA, Inc. Reports Third Quarter 2014 Financial Results 12/19/2014
NeuroDerm Ltd. (NDRM) Announces Third Quarter 2014 Financial Results And Provides A Corporate Update 12/18/2014
BioReference Laboratories, Inc. (BRLI) Announces Quarterly And Yearly Record Revenues, Net Income And Patient Volumes 12/18/2014
Amgen (AMGN) Announces 30 Percent Increase In 2015 First Quarter Dividend 12/18/2014
Neogen Corporation (NEOG) Reports 26% Increase In Net Income 12/18/2014
Baxter International, Inc. (BAX) Fourth Quarter 2014 Financial Results Conference Call 12/18/2014
PAREXEL International (PRXL) Announces Date Of Second Quarter Fiscal Year 2015 Earnings Release And Conference Call 12/17/2014
Bioanalytical Systems, Inc. (BASI) To Release Fourth Quarter Fiscal 2014 Results On Monday December 22, 2014; Conference Call & Webcast Set For 11:00 A.M. EST 12/17/2014
Bristol-Myers Squibb Company (BMY) To Announce Results For Fourth Quarter, Full Year 2014 On January 27 12/17/2014
Tenax Therapeutics (TENX) Announces Second Quarter Fiscal Year 2015 Financial Results 12/17/2014
Eagle Pharmaceuticals (EGRX) Reports Fourth Quarter And Year End 2014 Financial Results 12/17/2014
Coherus Biosciences Reports Third Quarter 2014 Financial And Operating Results 12/16/2014
PDL BioPharma, Inc. (PDLI) Completes Regular Quarterly Dividend Payment 12/16/2014
Helix Biopharma (TSX:HBP) Announces Q1 Fiscal 2015 Results 12/16/2014
Landauer (LDR)Announces Date And Time For Announcement Of Fiscal Fourth Quarter 2014 Results And Conference Call 12/15/2014
Origin Agritech Limited (SEED) To Announce Fiscal 2014 Annual Financial Results On January 8th, 2015 12/15/2014
Xenon Pharmaceuticals Inc. Reports Third Quarter 2014 Financial Results 12/15/2014
Polydex Pharmaceuticals (POLXF) Reports 3rd Quarter Financial Results 12/15/2014
Bioanalytical Systems, Inc. (BASI) To Release Fourth Quarter Fiscal 2014 Results On Wednesday December 17, 2014; Conference Call & Webcast Set For 11:00 A.M. EST 12/15/2014
Champions Oncology, Inc. (CSBR) Reports Results For The Second Quarter Ended October 31, 2014 12/12/2014
Peregrine Pharmaceuticals, Inc. (PPHM) Reports Second Quarter Fiscal Year 2015 Financial Results And Recent Developments 12/12/2014
Abbott Laboratories (ABT) Announces Increase In Quarterly Dividend 12/12/2014
Abzena PLC Release: Interim Results For The Six Months Ended 30 September 2014 12/11/2014
Tenax Therapeutics (TENX) To Provide Corporate Update And Discuss Second Quarter Fiscal Year 2015 Financial Results On December 17, 2014 12/11/2014
BioReference Laboratories, Inc. (BRLI) Announces Earnings Date For Fourth Quarter And Year End For Fiscal Year 2014 12/11/2014
Synergetics USA, Inc. (SURG) Reports First Quarter Of Fiscal Year 2015 Results 12/11/2014
Peregrine Pharmaceuticals, Inc. (PPHM) Declares Quarterly Dividend On Its Series E Convertible Preferred Stock 12/11/2014
Parnell Pharmaceuticals Holdings Announces Change In Fiscal Year-End 12/10/2014
Champions Oncology, Inc. (CSBR) To Announce Second Quarter Financial Results On Friday, December 12 12/10/2014
Dynasil Schedules Fiscal 2014 Financial Results Conference Call 12/10/2014
Enzo Biochem (ENZ) Reports Strong Fiscal First Quarter Results 12/10/2014
Bristol-Myers Squibb Company (BMY) Announces Dividend 12/10/2014
Scancell Holdings Plc Interim Results For The Six Months Ended 31 October 2014 12/10/2014
Patterson Companies Declares Quarterly Dividend 12/10/2014
AVANIR Pharmaceuticals (AVNR) Cancels Previously Scheduled Earnings Call 12/8/2014
OncoSec Medical Inc. Announces First Quarter Results For Fiscal Year End 2015 12/8/2014
Aceto Corporation Board Of Directors Declares Quarterly Cash Dividend 12/5/2014
Eagle Pharmaceuticals (EGRX) To Discuss 2014 Fourth Quarter And Year-End Financial Results On December 17, 2014 12/5/2014
Coherus Biosciences To Host Earnings Conference Call On December 15 12/5/2014
Peregrine Pharmaceuticals, Inc. (PPHM) To Report Second Quarter Fiscal 2015 Financial Results After Market On December 10, 2014 12/5/2014
Consort Medical Interim Results For The Six Months Ended 31 October 2014 12/4/2014
Simulations Plus (SLP) Reports First Quarter FY2015 Preliminary Revenues 12/3/2014
Nevro Corp Reports Third Quarter Financial Results 12/3/2014
Auris Medical AG (EARS) Q3 2014 Earnings Release 12/3/2014
AVANIR Pharmaceuticals (AVNR) Announces Date Of Fiscal 2014 Fourth Quarter Financial Results And Conference Call 12/2/2014
Synergetics USA, Inc. (SURG) Announces Conference Call To Review First Quarter Of Fiscal Year 2015 Results 12/2/2014
GW Pharmaceuticals plc Reports 2014 Q4 And Full Year Financial Results 12/2/2014
Pivotal Therapeutics Inc. Announces Third Quarter Accomplishments And Financial Results 12/1/2014
Auris Medical AG (EARS) To Announce Third Quarter 2014 Financial Results And Host Conference Call On Wednesday, December 3, 2014 12/1/2014
uniQure Announces Results For The Third Quarter Of 2014 12/1/2014
iCo Therapeutics Inc. Announces Third Quarter 2014 Financial Results And Corporate Update 12/1/2014
Antibe Therapeutics Inc. Reports Q2 2015 Interim Financial And Operating Results 12/1/2014
XTL Biopharmaceuticals Ltd. (XTLB) Provides Financial and Operational Update For the Third Quarter of 2014 12/1/2014
Simulations Plus (SLP) Reports FY2014 And Fourth Quarter FY2014 Financial Results 11/26/2014
Arrowhead Research Corporation (ARWR) Reports Fiscal 2014 Year End Financial Results 11/26/2014
China Cord Blood Corporation Reports Financial Results For The Second Quarter And First Half Of Fiscal 2015 11/26/2014
Analogic Corporation (ALOG) Announces Timing For First Quarter 2015 Earnings Conference Call And Webcast 11/26/2014
Pall Corporation (PLL) Reports First Quarter Results 11/25/2014
Proteon Therapeutics, Inc. (PRTO) Announces Third Quarter 2014 Financial Results 11/25/2014
Enanta Pharmaceuticals, Inc. Reports Financial Results For its Fiscal Fourth Quarter And Year Ended September 30, 2014 11/24/2014
GW Pharmaceuticals To Report Q4, Year-End 2014 Financial Results And Host Conference Call On 2 December, 2014 11/24/2014
Bio Blast Pharma Reports Third Quarter Financial Results 11/21/2014
Taxus Cardium (CRXM) Reports On Third Quarter 2014 Results And Corporate Development Activities 11/20/2014
Medivir AB (MVRBF): Interim Report, January – September 2014 11/20/2014
Cellular Biomedicine Group (CBMG) Reports Third Quarter 2014 Financial Results And Provides Business Highlights 11/20/2014
EDAP TMS S.A. (EDAP) Reports Continued Strong Growth In Third Quarter 2014 11/20/2014
Sientra, Inc. (SIEN) Reports Third Quarter 2014 Financial Results 11/20/2014
NeuroVive Pharmaceutical AB: Interim Report 1 Jan. 2014 To 30 Sep. 2014 11/19/2014
Mallinckrodt plc Reports Fiscal 2014 Fourth Quarter And Fiscal 2014 Financial Results 11/19/2014
Marina Biotech, Inc. (MRNA) Announces Third Quarter 2014 Financial Results 11/19/2014
Arrowhead Research Corporation (ARWR) To Report Fiscal 2014 Fourth Quarter And Year End Financial Results 11/19/2014
Cardio3 BioSciences Announces Q3 2014 Business Update 11/18/2014
Agilent Technologies Inc. (A) Reports Fourth-Quarter 2014 Results 11/18/2014
MYOS (MYOS) Reports 2014 Third Quarter Results And Provides Business Update 11/18/2014
Skystar Bio-Pharmaceutical (CGPN) To File Financial Results For Third Quarter Of Fiscal 2014 On Friday, November 14 11/18/2014
Skystar Bio-Pharmaceutical (CGPN) Reports Third Quarter Fiscal Year 2014 Financial Results 11/18/2014
ContraFect Corporation (CFRXU) Announces Third Quarter 2014 Results 11/18/2014
Elite Pharmaceuticals, Inc. (ELI) Reports Financial Results For The Second Quarter Of Fiscal Year 2015 11/18/2014
Palatin Technologies (PTN) Reports First Quarter Fiscal Year 2015 Results; Teleconference And Webcast To Be Held On November 18, 2014 11/18/2014
Omega Protein Corporation (OME) Announces Third Quarter 2014 Financial Results 11/18/2014
China Cord Blood Corporation To Report Second Quarter And First Half Of Fiscal 2015 Financial Results 11/18/2014
Protea Biosciences, Inc. Announces 2014 Third Quarter Financial Results 11/18/2014
Affimed Reports Financial Results For Third Quarter 2014 11/18/2014
Fermentalg Q3 2014 Financial information 11/17/2014
Kite Pharma, Inc. (KITE) Reports Third Quarter 2014 Results 11/17/2014
Tengion Inc. Provides Clinical Update And Reports Third Quarter 2014 Financial Results And Cash Position 11/17/2014
VBI Reports Third Quarter 2014 Financial Results And Provides Update On CMV Vaccine Development 11/17/2014
Arno Therapeutics Reports Third Quarter 2014 Financial And Business Update 11/17/2014
Alcobra (ADHD) Announces Third Quarter Financial Results And Provides Corporate Update 11/17/2014
ConvaTec Announces 2014 Third Quarter Earnings Call 11/17/2014
Inergetics, Inc.: 2014 Third Quarter Earnings Announcement 11/17/2014
Nephros Inc. (NEP) Reports Third Quarter 2014 Financial Results And Announces Launch Of Rights Offering 11/17/2014
Anthera Pharmaceuticals, Inc. (ANTH) Reports 2014 Third Quarter Financial Results And Operational Update 11/17/2014
Sinovac Biotech Ltd. (SVA) Reports Unaudited Third Quarter Financial Results 11/17/2014
ULURU Inc. Reports Third Quarter 2014 Financial Results 11/17/2014
Pressure BioSciences, Inc. (BBII) Reports Third Quarter 2014 Financial Results And Provides Business Update 11/17/2014
ProSensa Holding N.V. (RNA) Announces 3rd Quarter 2014 Financial Results And Recent Corporate Developments 11/17/2014
WuXi PharmaTech Co., Ltd. Reports Record Revenues, CapEx Spending 11/17/2014
Sevion Therapeutics Reports First Quarter 2015 Financial Results 11/17/2014
Corium International, Inc. Reports Fiscal Year-End 2014 Financial Results And Recent Corporate Developments 11/17/2014
Enumeral Biomedical (ENUM) Reports Third Quarter 2014 Financial Results 11/17/2014
Bio-Path Holdings, Inc. (BPTH) Reports Third Quarter 2014 Operational And Financial Results 11/17/2014
Enanta Pharmaceuticals, Inc. To Host Conference Call To Discuss Financial Results For The Fiscal Fourth Quarter And Year Ended September 30, 2014 11/17/2014
Retrophin (RTRX) Reports Third Quarter 2014 Financial Results 11/14/2014
BIOQUAL Presents Financial Results For Fiscal Year 2014 And Declares Dividend 11/14/2014
Nuo Therapeutics Reports Third Quarter 2014 Financial Results 11/14/2014
AxoGen, Inc. (AXGN) Reports 58% Third Quarter Revenue Growth 11/14/2014
Ruthigen Reports Fiscal Second Quarter 2015 Financial Results 11/14/2014
Kindred Bio (KIN) Announces Third Quarter 2014 Financial Results 11/14/2014
Intrexon Corporation Announces Third Quarter 2014 Financial Results 11/14/2014
Celator Pharmaceuticals, Inc. Announces Business Update And Third Quarter 2014 Financial Results 11/14/2014
Pfenex Inc. (PFNX) Reports Third Quarter 2014 Results And Provides Business Update 11/14/2014
Dyadic International, Inc. Reports Q3 2014 Financial Results 11/14/2014
Capstone Therapeutics (CAPS) Will Provide An Operating Update And Announces Third Quarter 2014 Financial Results 11/14/2014
CollabRx, Inc. Reports Second Quarter Fiscal Year 2015 Financial Results 11/14/2014
Cesca Therapeutics Reports First Quarter Fiscal 2015 Results 11/14/2014
Calithera Biosciences, Inc. (CALA) Reports Financial Results For The Fiscal Quarter Ended September 30, 2014 11/14/2014
Palatin Technologies (PTN) To Report First Quarter Fiscal Year 2015 Results 11/14/2014
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Third Quarter 2014 Financial Results 11/14/2014
Foamix Pharmaceuticals, Ltd. (FOMX) Reports Financial Results For Third Quarter And Nine Months Ended September 30, 2014 11/14/2014
China Pharma Holdings, Inc. (CPHI.OB) Reports Third Quarter 2014 Financial Results 11/14/2014
Synthetic Biologics, Inc. (SYN) Reports Third Quarter 2014 Financial Results And Operational Highlights 11/14/2014
CASI Pharmaceuticals  (ENMD) Reports Third Quarter 2014 Financial Results 11/14/2014
Flexion Therapeutics (FLXN) Reports Third-Quarter 2014 Financial Results 11/14/2014
Vital Therapies, Inc. (VTI) (VTL) Announces Third Quarter 2014 Financial Results And Provides A Corporate Update 11/14/2014
Agile Therapeutics, Inc. Reports Third Quarter 2014 Financial Results 11/14/2014
Argos Therapeutics, Inc. (ARGS) Reports Third Quarter 2014 Financial Results And Operational Highlights 11/14/2014
Evoke Pharma, Inc. Reports Third Quarter 2014 Results 11/14/2014
Ocera Therapeutics, Inc. (OCRX) Reports Third Quarter 2014 Financial Results 11/14/2014
Nymox Pharmaceutical (NYMX) Reports Third Quarter 2014 Financial Results 11/14/2014
Elite Pharmaceuticals, Inc. (ELI) To Host Quarterly Business Update Call On Wednesday, November 19, 2014 11/14/2014
FEI Company Announces Quarterly Cash Dividend Of $0.25 Per Share 11/14/2014
Cerulean Pharma Inc. (CERU) Reports Third-Quarter 2014 Corporate Highlights And Financial Results 11/14/2014
Emisphere Technologies, Inc. (EMIS) Announces Financial Results For The Third Quarter 2014 11/14/2014



//-->